Using a multiplex serological assay to estimate time since SARS-CoV-2 infection and past clinical presentation in malagasy patients

Using a multiplex serological assay to estimate time since SARS-CoV-2 infection and past clinical presentation in malagasy patients

Background: The world is facing a 2019 coronavirus (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this context, efficient serological assays are needed to accurately describe the humoral responses against the virus. These tools could potentially provid...

Full description

Bibliographic Details
Main Authors: Mame Diarra Bousso Ndiaye, Lova Tsikiniaina Rasoloharimanana, Solohery Lalaina Razafimahatratra, Rila Ratovoson, Voahangy Rasolofo, Paulo Ranaivomanana, Laurent Raskine, Jonathan Hoffmann, Rindra Randremanana, Niaina Rakotosamimanana, Matthieu Schoenhals
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Heliyon
Subjects:
SARS-CoV-2 antibodies
COVID-19 seroprevalence
Prediction model
Madagascar
Symptom presentation
Time since infection
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023044729

Internet

http://www.sciencedirect.com/science/article/pii/S2405844023044729

Similar Items